Samsung Medison

What Samsung Medison does

Samsung Medison Co., Ltd. is a South Korea-based medical imaging company and wholly-owned subsidiary of Samsung Electronics, specializing in ultrasound diagnostic systems. Founded in 1985 as Medison Co., Ltd. and integrated into Samsung Electronics in 2011, the company is the largest manufacturer of ultrasound diagnostic systems in Korea and operates two manufacturing facilities in Hongcheon-gun and Gumi-si alongside its Seoul headquarters. Its product portfolio spans premium radiology systems (R20, RS85 Prestige), obstetrics and gynecology systems (HERA Z20, HERA W10 Elite), and mid-range/portable general imaging devices (V8, V7, V6, HM70 EVO), augmented by digital radiography and portable CT through its NeuroLogica subsidiary. The company has integrated Samsung's semiconductor, IT, and signal-processing technologies into its devices and maintains a portfolio of FDA 510(k)-cleared AI features including HeartAssist, NerveTrack, Uterine Assist, BiometryAssist, and ViewAssist.

Samsung Medison generates revenue primarily through hardware sales of ultrasound diagnostic systems to enterprise healthcare customers, supplemented by AI software modules and service contracts. Its go-to-market relies on direct enterprise field sales targeting academic medical centers and regional healthcare networks, with named US customers including Cleveland Clinic and Mayo Clinic, and the company pursues geographic expansion through Samsung HME America in the US and partnerships such as the HistoSonics collaboration for therapeutic ultrasound. Recent strategic actions include the $92.7 million acquisition of France-based Sonio (August 2024) for 3D/5D prenatal imaging AI, the launch of the R20 (December 2025) and HERA Z20 (2025) flagship systems, the unification of US operations under Samsung HME America (March 2026), and a partnership with HistoSonics (March 2026) extending into therapeutic applications. North American revenue grew 69% from 16.4 billion KRW in 2023 to 27.7 billion KRW in 2025.

Name

Samsung Medison

Legal name

Samsung Medison Co., Ltd.

Website

https://samsungmedison.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Samsung Medison is a South Korea-based, Samsung Electronics-owned manufacturer of ultrasound diagnostic systems, AI-powered imaging software, and digital radiography/CT equipment serving enterprise hospitals and maternal-fetal medicine centers globally.

Ownership category

akta.pro rank

Product category

Medical Imaging Equipment

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Ultrasound & Echography Systems (HLAHABAD)

akta.pro secondary industries

Portable, Mobile & Point-of-Care Imaging Systems (HLAHABAL), Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH)

Keywords

• Diagnostic ultrasound systems
• Medical imaging equipment
• AI diagnostic tools
• Radiology imaging devices
• OB/GYN ultrasound systems

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Ultrasound Diagnostic Systems Hardware: Samsung Medison generates revenue primarily from selling premium and mid-range ultrasound diagnostic systems to healthcare providers. The company sells radiology ultrasound systems, obstetrics/gynecology ultrasound systems, and portable ultrasound devices to hospitals, clinics, and diagnostic imaging centers.
2. AI Software and Diagnostics: Revenue from AI-powered diagnostic software tools including BiometryAssist, ViewAssist, and other AI medical devices approved by regulatory bodies like FDA.
3. Service and Support: The company provides service support including a dedicated service line (1644-0550) and product/service request capabilities through Samsung Healthcare website.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Samsung Medison manufactures and sells diagnostic ultrasound systems for radiology, obstetrics/gynecology, and general imaging applications. The products integrate a proprietary Advanced Imaging Engine, FDA-cleared AI diagnostic assistance tools, and ergonomic hardware design such as the Flex Cable. The company markets to hospitals, clinics, and diagnostic imaging centers globally through direct enterprise sales channels and regional subsidiaries including Samsung HME America.

Product overview

Samsung Medison is a professional manufacturer of ultrasound diagnostic devices and medical imaging equipment. The company's product portfolio includes premium, midrange, and portable ultrasound systems across three main segments: radiology (RS85 Prestige, R20), obstetrics and gynecology (HERA Z20, HERA W10 Elite, HERA W10), and general imaging (V8, V7, V6, HM70 EVO portable). The company also offers AI-powered diagnostic add-on modules including BiometryAssist, ViewAssist, NerveTrack, Uterine Assist, and HeartAssist for fetal growth diagnosis, neural tracking, and cardiac assessment. Samsung Medison additionally provides digital radiography and portable CT systems, with recent expansion into therapeutic ultrasound through partnership with HistoSonics.

Differentiator

Problem solved

Functional benefit

Brands

• NeuroLogica: CT scanner brand consolidated under Samsung HME America
• Boston Imaging

Products and services

• R20 Radiology Ultrasound System

Quantifiable outcome

• North American revenue grew 69% from 16.4 billion won (2023) to 27.7 billion won (2025)
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability12 records

Feature10 records

Partnerships

Five partnerships are on record, tiered core and minor.

• HistoSonicscoreStrategic or Co-development Partner · 9 March 2026Samsung Medison partnered with U.S.-based HistoSonics to integrate its R20 premium ultrasound diagnostic system with HistoSonics' Edison platform, which uses histotripsy to non-invasively destroy tumors without incisions. The collaboration enables real-time imaging during histotripsy procedures, marking Samsung Medison's expansion from diagnostic ultrasound into therapeutic applications. HistoSonics holds FDA De Novo clearance (secured in 2023) and raised funding at approximately $2.25 billion enterprise valuation. The partnership aims to pioneer new markets in ultrasound-based treatment.
• Samsung HME America (Formerly NeuroLogica and Boston Imaging)coreTechnology or Integration · 1 March 2026Samsung Medison unified its two U.S. medical imaging businesses (NeuroLogica and Boston Imaging) under a new corporate identity called Samsung HME (Healthcare and Medical Equipment) America. The consolidation integrates ultrasound, digital radiography, and CT operations under a single structure aligned with the global Samsung brand. Samsung HME America serves as global headquarters and manufacturing hub for CT business, including development of photon counting detector technology.
• SoniocoreStrategic or Co-development Partner · 1 August 2024Samsung Medison acquired France-based Sonio, a company specializing in 3D and 5D ultrasound imaging technologies, for approximately $92.7 million in August 2024. The acquisition aims to integrate advanced fetal imaging technology with maternal healthcare solutions and strengthen Samsung Medison's presence in healthcare imaging. Sonio's technology enhances prenatal care diagnostics through AI-powered prenatal ultrasound capabilities.
• Fetal Medicine Foundation (FMF)minorStrategic or Co-development PartnerSamsung Medison sponsored training to Ethiopian healthcare professionals hosted by FMF (Fetal Medicine Foundation) in 2023, demonstrating commitment to global healthcare access and prenatal care training.
• Naver HealthcareminorStrategic or Co-development PartnerSamsung Medison partnered with Naver Healthcare for digital symptom screening tools, as showcased at KIMES 2026 exhibition in Seoul along with AI-based health monitoring devices.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• GE HealthCare: Largest ultrasound competitor globally with broad radiology, OB/GYN, and point-of-care portfolio (LOGIQ, Voluson, Vscan). Directly competes with Samsung Medison's R20, HERA Z20, and HM70 EVO in the same hospital segments.
• Philips: Major ultrasound competitor with EPIQ, Affiniti, and Lumify product lines covering radiology, OB/GYN, and cardiac. Competes head-to-head with Samsung Medison in premium hospital and women's health imaging.
• Siemens Healthineers: Ultrasound competitor with ACUSON family targeting radiology, OB/GYN, and cardiology, plus AI-Rad Companion. Direct overlap with Samsung Medison's premium radiology and HERA OB/GYN offerings.
• Mindray: Chinese medical device manufacturer with rapidly growing ultrasound portfolio (Resona, DC-80, TE7). Directly competes with Samsung Medison in mid-tier radiology and point-of-care segments, often at lower price points.
• Canon Medical Systems: Japanese competitor with Aplio and Xario ultrasound systems serving radiology and OB/GYN markets. Comparable to Samsung Medison in premium radiology and women's health imaging.
• FUJIFILM Healthcare: Offers ultrasound systems alongside its broader medical imaging portfolio (including acquired Hitachi diagnostic imaging business). Directly competes in radiology ultrasound with Samsung Medison's RS-series products.

Emerging players

• Butterfly Network: Handheld, single-probe whole-body ultrasound using semiconductor technology. Competes in point-of-care segment with Samsung Medison's HM70 EVO and portable offerings, though focused on a different price/use-case profile.
• Clarius Mobile Health: Wireless handheld ultrasound for point-of-care and bedside use. Overlaps with Samsung Medison's portable HM70 EVO segment in mobile/portable clinical environments.

Broad incumbents

• Hologic: Major women's health imaging player (SuperSonic MACH ultrasound, NovaSure, mammography). Adjacent competitor in women's health/OB-GYN imaging where Samsung Medison's HERA Z20 competes.

Others

• HistoSonics: Edison histotripsy platform partner integrated with Samsung Medison's R20 for therapeutic ultrasound. Connected via strategic partnership rather than direct product competition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/Samsung_HealthC
• LinkedInlinkedin.com/company/samsung-medison-brasil

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Samsung Medison